داروسازی زاگرس فارمد پارس
ددام | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/06/22 Fiscal Year 2026/03/2012 Month | 2025/06/01 Fiscal Year 2025/03/2012 Month | 2024/06/08 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 42.558 Billion | 240.568 Billion | 289.445 Billion | |
Short-Term Investments | - | - | 37.108 Billion | |
Trade Receivables | 10.279 Trillion | 8.124 Trillion | 6.785 Trillion | |
Prepayments | 168.29 Billion | 461.367 Billion | 335.364 Billion | |
Raw Materials & Packaging Inventory | 1.489 Trillion | 380.301 Billion | 940.012 Billion | |
Work-in-Progress Inventory | 56.948 Billion | 470 Million | - | |
Finished Goods Inventory | 25.445 Billion | 1.903 Billion | - | |
Spare Parts Inventory | 20.503 Billion | 19.568 Billion | - | |
Our Goods on Consignment with Others | 31.226 Billion | - | - | |
Other Inventories | 1.501 Billion | 3.186 Billion | - | |
Inventories | 1.625 Trillion | 405.428 Billion | 940.012 Billion | |
Total Current Assets | 12.114 Trillion | 9.231 Trillion | 8.387 Trillion | |
Long-Term Investments | 175 Million | 85 Million | 85 Million | |
Intangible Assets | 15.864 Billion | 17.207 Billion | 12.496 Billion | |
Other Assets | 96.21 Billion | 108.701 Billion | 108.701 Billion | |
Property, Plant & Equipment | 2.179 Trillion | 2.276 Trillion | 2.392 Trillion | |
Net Fixed Assets | 2.179 Trillion | 2.276 Trillion | 2.392 Trillion | |
Total Non-Current Assets | 2.292 Trillion | 2.402 Trillion | 2.513 Trillion | |
Total Assets | 14.406 Trillion | 11.633 Trillion | 10.9 Trillion | |
Trade Payables | 2.57 Trillion | 1.922 Trillion | 1.745 Trillion | |
Advances Received | 296.25 Billion | - | - | |
Income Tax Provision | 1.033 Trillion | 665.245 Billion | 449.306 Billion | |
Proposed & Payable Dividends | 3.626 Trillion | 2.544 Trillion | 1.488 Trillion | |
Current Borrowings | 790.964 Billion | 1.178 Trillion | 2.133 Trillion | |
Total Current Liabilities | 8.315 Trillion | 6.309 Trillion | 5.815 Trillion | |
Employee Termination Benefits Provision | 417.091 Billion | 263.52 Billion | 181.562 Billion | |
Total Non-Current Liabilities | 489.134 Billion | 353.574 Billion | 289.627 Billion | |
Total Liabilities | 8.804 Trillion | 6.662 Trillion | 6.105 Trillion | |
Capital | 2.821 Trillion | 2.821 Trillion | 1.15 Trillion | |
Retained Earnings | 2.684 Trillion | 2.13 Trillion | 2.005 Trillion | |
Legal Reserve | 282.059 Billion | 212.376 Billion | 115 Billion | |
Share Premium Reserve | -185.533 Billion | -191.556 Billion | -145.313 Billion | |
Total Equity | 5.601 Trillion | 4.971 Trillion | 4.795 Trillion | |
Total Liabilities & Equity | 14.406 Trillion | 11.633 Trillion | 10.9 Trillion | |
Approved Capital | 2.821 Trillion | 2.821 Trillion | 1.15 Trillion | |
Approved Retained Earnings | 583.035 Billion | 127.12 Billion | 279.595 Billion | |
Approved Legal Reserve | 282.059 Billion | 212.376 Billion | 115 Billion | |
Total Approved Equity (at AGM) | 3.686 Trillion | 3.16 Trillion | 1.545 Trillion | |
درآمد انتقالی به دورههای آتی | 72.043 Billion | 90.054 Billion | 108.065 Billion | |
Revaluation Surplus of Property, Plant and Equipment | - | - | 1.671 Trillion |